Latest Privium Fund Management B.V. Stock Portfolio
Privium Fund Management B.V. Performance:
2025 Q1: -10.9%YTD: -10.9%2024: 19.82%
Performance for 2025 Q1 is -10.9%, and YTD is -10.9%, and 2024 is 19.82%.
About Privium Fund Management B.V. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Privium Fund Management B.V. reported an equity portfolio of $383.6 Millions as of 31 Mar, 2025.
The top stock holdings of Privium Fund Management B.V. are , TSLA, . The fund has invested 21% of it's portfolio in SPOTIFY TECHNOLOGY S A and 15% of portfolio in TESLA INC.
The fund managers got completely rid off INTRA-CELLULAR THERAPIES INC (ITCI), NUSCALE PWR CORP (SMR) and IONQ INC (IONQ) stocks. They significantly reduced their stock positions in MEIRAGTX HLDGS PLC (MGTX), MERCK & CO INC (MRK) and COUPANG INC (CPNG). Privium Fund Management B.V. opened new stock positions in SPRINGWORKS THERAPEUTICS INC (SWTX), VERTEX PHARMACEUTICALS INC (VRTX) and ALNYLAM PHARMACEUTICALS INC (ALNY). The fund showed a lot of confidence in some stocks as they added substantially to UROGEN PHARMA LTD (URGN), INTELLIA THERAPEUTICS INC (NTLA) and CRISPR THERAPEUTICS AG (CRSP).
The top stock holdings of Privium Fund Management B.V. are , TSLA, . The fund has invested 21% of it's portfolio in SPOTIFY TECHNOLOGY S A and 15% of portfolio in TESLA INC.
The fund managers got completely rid off INTRA-CELLULAR THERAPIES INC (ITCI), NUSCALE PWR CORP (SMR) and IONQ INC (IONQ) stocks. They significantly reduced their stock positions in MEIRAGTX HLDGS PLC (MGTX), MERCK & CO INC (MRK) and COUPANG INC (CPNG). Privium Fund Management B.V. opened new stock positions in SPRINGWORKS THERAPEUTICS INC (SWTX), VERTEX PHARMACEUTICALS INC (VRTX) and ALNYLAM PHARMACEUTICALS INC (ALNY). The fund showed a lot of confidence in some stocks as they added substantially to UROGEN PHARMA LTD (URGN), INTELLIA THERAPEUTICS INC (NTLA) and CRISPR THERAPEUTICS AG (CRSP).
Privium Fund Management B.V. Annual Return Estimates Vs S&P 500
Our best estimate is that Privium Fund Management B.V. made a return of -10.9% in the last quarter. In trailing 12 months, it's portfolio return was 6.61%.
New Buys
| Ticker | $ Bought |
|---|---|
| springworks therapeutics inc | 5,471,240 |
| vertex pharmaceuticals inc | 4,024,010 |
| alnylam pharmaceuticals inc | 1,543,430 |
| immunovant inc | 1,230,480 |
| voyager therapeutics inc | 73,160 |
New stocks bought by Privium Fund Management B.V.
Additions
| Ticker | % Inc. |
|---|---|
| urogen pharma ltd | 288 |
| intellia therapeutics inc | 111 |
| crispr therapeutics ag | 71.72 |
| arrowhead pharmaceuticals in | 65.33 |
| vizsla silver corp | 65.2 |
| pfizer inc | 47.09 |
| valaris ltd | 42.59 |
| noble corp plc | 35.74 |
Additions to existing portfolio by Privium Fund Management B.V.
Reductions
| Ticker | % Reduced |
|---|---|
| meiragtx hldgs plc | -48.02 |
| merck & co inc | -43.41 |
| coupang inc | -42.28 |
| roivant sciences ltd | -41.1 |
| snowflake inc | -36.00 |
| zai lab ltd | -28.57 |
| uniqure nv | -21.97 |
| american intl group inc | -19.2 |
Privium Fund Management B.V. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| nuscale pwr corp | -6,454,820 |
| immatics n.v | -67,333 |
| composecure inc | -692,166 |
| gcm grosvenor inc | -173,639 |
| ionq inc | -3,898,910 |
| ast spacemobile inc | -2,352,650 |
| intra-cellular therapies inc | -8,114,300 |
| b2gold corp | -207,756 |
Privium Fund Management B.V. got rid off the above stocks
Sector Distribution
Privium Fund Management B.V. has about 41.6% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 41.6 |
| Consumer Cyclical | 22.5 |
| Healthcare | 21.6 |
| Technology | 13.7 |
Market Cap. Distribution
Privium Fund Management B.V. has about 40.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 41.7 |
| MEGA-CAP | 25 |
| LARGE-CAP | 15.7 |
| MID-CAP | 12.6 |
| SMALL-CAP | 4.9 |
Stocks belong to which Index?
About 37.4% of the stocks held by Privium Fund Management B.V. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 62.6 |
| S&P 500 | 27 |
| RUSSELL 2000 | 10.4 |
Privium Fund Management B.V. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Privium Fund Management B.V.
Privium Fund Management B.V. has 56 stocks in it's portfolio. About 77.1% of the portfolio is in top 10 stocks. TSLA proved to be the most loss making stock for the portfolio. PLTR was the most profitable stock for Privium Fund Management B.V. last quarter.
Last Reported on: 09 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 0.64 | 148,400 | 2,464,920 | unchanged | 0.00 | ||
| AIG | american intl group inc | 0.15 | 6,483 | 563,632 | reduced | -19.2 | ||
| ALNY | alnylam pharmaceuticals inc | 0.40 | 5,716 | 1,543,430 | new | |||
| ALXO | alx oncology hldgs inc | 0.08 | 509,059 | 317,144 | unchanged | 0.00 | ||
| AMZN | amazon com inc | 7.03 | 141,000 | 26,969,300 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 1.33 | 325,709 | 5,094,090 | unchanged | 0.00 | ||
| ARWR | arrowhead pharmaceuticals in | 2.09 | 629,214 | 8,016,190 | added | 65.33 | ||
| ASTS | ast spacemobile inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 0.10 | 251,674 | 390,094 | added | 8.63 | ||
| AXSM | axsome therapeutics inc | 1.60 | 52,732 | 6,150,130 | reduced | -15.27 | ||
| CMPO | composecure inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CPNG | coupang inc | 0.48 | 81,900 | 1,831,280 | reduced | -42.28 | ||
| CRSP | crispr therapeutics ag | 0.53 | 60,097 | 2,045,100 | added | 71.72 | ||
| DYN | dyne therapeutics inc | 0.07 | 27,566 | 288,340 | added | 35.35 | ||
| FATE | fate therapeutics inc | 0.02 | 109,026 | 86,141 | added | 25.32 | ||
| FDMT | 4d molecular therapeutics in | 0.11 | 131,000 | 423,130 | added | 8.26 | ||
| GCMG | gcm grosvenor inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| HCC | warrior met coal inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IMVT | immunovant inc | 0.32 | 72,000 | 1,230,480 | new | |||
| IONQ | ionq inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||